• No results found

NiZnFe/sub 2/O/sub 4/Sc/sub 2/O/sub 4/

Vancomycin-modified Fe3O4@SiO2@Ag microflowers as effective antimicrobial agents

Vancomycin-modified Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>@Ag microflowers as effective antimicrobial agents

... 3 O 4 @SiO 2 @Ag microflower with enhanced antibacterial activity is experimentally and theoretically presented in this ...3 O 4 @SiO 2 @Ag microflowers can rapidly and ...

18

Polyetherimide-grafted Fe3O4@SiO2 nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging

Polyetherimide-grafted Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging

... from healthy Sprague Dawley rats was collected in heparin- coated tubes. The red blood cells (RBCs) were obtained by centrifugation at 1,500 rpm for 5 minutes, and the upper plasma was removed. The RBCs were then washed ...

13

Immobilized transferrin Fe3O4@SiO2 nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery

Immobilized transferrin Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery

... DMP was suspended in 10 mL phosphate-buffered saline (PBS) solution, and incubated with 5 mg EDC and 5 mg NHS for 30 minutes at room temperature. Then, the products were separated using magnetic separation and ...

9

Biological responses to core&ndash;shell-structured Fe3O4@SiO2-NH2 nanoparticles in rats by a nuclear magnetic resonance-based metabonomic strategy

Biological responses to core&ndash;shell-structured Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticles in rats by a nuclear magnetic resonance-based metabonomic strategy

... a 2-week acclimatization for Fe@Si NP intravenous adminis- tration: control group, low-dose 10 nm Fe@Si NP-exposure group (10L), low-dose 20 nm Fe@Si NP-exposure group (20L), high-dose 20 nm Fe@Si NP-exposure ...

16

In vitro and in vivo targeting imaging of pancreatic cancer using a&nbsp;Fe3O4@SiO2&nbsp;nanoprobe modified with anti-mesothelin antibody

In vitro and in vivo targeting imaging of pancreatic cancer using a&nbsp;Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>&nbsp;nanoprobe modified with anti-mesothelin antibody

... Fe, O, C, N, and Si, so the result shows Si and antibodies are coated on the ...3 O 4 and SPIONs are most com- monly used for preparation of multifunctional nanoparticles due to their unique ...

13

Combination of PEI-Mn0.5Zn0.5Fe2O4 nanoparticles and pHsp 70-HSV-TK/GCV with magnet-induced heating for treatment of hepatoma

Combination of PEI-Mn<sub>0.5</sub>Zn<sub>0.5</sub>Fe<sub>2</sub>O<sub>4</sub> nanoparticles and pHsp 70-<em>HSV</em>-<em>TK</em>/GCV with magnet-induced heating for treatment of hepatoma

... The p-Stat3, Bcl-xL, and Bax proteins levels were determined by a protein imprinting method (Western blot). Proteins from the aforementioned groups were extracted in lysis buffer (RIPA, shenggong, shanghai People’s ...

15

Effect of Cobalt Precursors on Properties of Co/CoAl2O4 Catalysts Synthesized by Solvothermal Method

Effect of Cobalt Precursors on Properties of Co/CoAl<sub>2</sub>O<sub>4</sub> Catalysts Synthesized by Solvothermal Method

... Here, different cobalt precursors, such as cobalt (II) acetylacetonate, cobalt (II) acetate, cobalt (II) nitrate and cobalt (II) chloride, were employed to synthesize the cobalt on cobalt-aluminate catalysts. It revealed ...

10

Biosafety evaluation of Janus Fe3O4-TiO2 nanoparticles in Sprague Dawley rats after intravenous injection

Biosafety evaluation of Janus Fe<sub>3</sub>O<sub>4</sub>-TiO<sub>2</sub> nanoparticles in Sprague Dawley rats after intravenous injection

... Biochemical and hematological analyses were performed with a 7600-110 autoanalyzer (Hitachi Ltd., Tokyo, Japan) and blood analyzer (XT-1800i; Sysmex Corporation, Kobe, Japan), respectively. Metal content (Ti and Fe) was ...

15

Biocompatibility of magnetic Fe3O4 nanoparticles and their cytotoxic effect on MCF-7 cells

Biocompatibility of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and their cytotoxic effect on MCF-7 cells

... aged 4 weeks and weighing 20–22 g were divided into six groups, with 10 mice per group (half male and half ...3 O 4 , sterile normal saline was added to prepare mixed suspensions of different ...

10

Preparation of Fe3O4 magnetic nanoparticles coated with gallic acid for drug delivery

Preparation of Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles coated with gallic acid for drug delivery

... (FeCl 2 ⋅ 4H 2 O $ 99%) and iron (III) chloride hexahy- drate (FeCl 3 ⋅ 6H 2 O, 99%) were purchased from Merck KGaA (Darmstadt, ...

12

Synthesis of composite magnetic nanoparticles&nbsp;Fe3O4&nbsp;with alendronate for osteoporosis treatment

Synthesis of composite magnetic nanoparticles&nbsp;Fe<sub>3</sub>O<sub>4</sub>&nbsp;with alendronate for osteoporosis treatment

... 3 O 4 , Dex/Fe 3 O 4 , and Bis/Dex/Fe 3 O 4 was verified by XRD (Figure ...3 O 4 pattern published by ...3 O 4 and Bis/Dex/ Fe 3 O 4 was ...

12

Software Module of Mathematical Chemistry Web Laboratory for Studying the Kinetics of Oxidation of 4 tert Butyl phenol by Aqueous Solution of H2O2 in the Presence of Titanosilicates

Software Module of Mathematical Chemistry Web Laboratory for Studying the Kinetics of Oxidation of 4 tert Butyl phenol by Aqueous Solution of H<sub>2</sub>O<sub>2</sub> in the Presence of Titanosilicates

... solution feed time can be shortened from 10 minutes to 5-6 minutes depending on the reaction temperature, as significant changes in concentration of the reactants after five minutes at each feeding step occurs (Fig. ...

8

Fe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis

Fe<sub>3</sub>O<sub>4</sub>-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis

... 3 O 4 -PLGA NP group and the Fe 3 O 4 -PLGA- cRGD NP ...h, 2 h, and 3 h after injection of the ...3 O 4 -PLGA or Fe 3 O 4 -PLGA- cRGD ...

14

In vitro toxicity of FemOn, FemOn-SiO2 composite, and SiO2-FemOn core-shell magnetic nanoparticles

In vitro toxicity of Fe<sub>m</sub>O<sub>n</sub>, Fe<sub>m</sub>O<sub>n</sub>-SiO<sub>2</sub> composite, and SiO<sub>2</sub>-Fe<sub>m</sub>O<sub>n</sub> core-shell magnetic nanoparticles

... m O n -SiO 2 composite flake-like, and SiO 2 -Fe m O n core-shell IONPs on cell viability, function, and mor- phology were tested 48 h postincubation in human umbilical vein endothelial cell ...

11

Effect of interaction of magnetic nanoparticles of Fe3O4 and artesunate on apoptosis of K562 cells

Effect of interaction of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> and artesunate on apoptosis of K562 cells

... 3 O 4 was kindly supplied by the state Key Laboratory of Bioelectronics, Southeast University, Nanjing, China, and was well distributed in ...3 O 4 colloidal ...3 O 4 , at the ...

8

The effect of magnetic nanoparticles of Fe3O4 on immune function in normal ICR mice

The effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> on immune function in normal ICR mice

... Mice were randomly assigned to one of four groups (n = 10 per group). The doses of 5.14 mg/kg (low dose group), 20.7 mg/kg (medium dose group), and 51.4 mg/kg (high dose group) Fe 3 O 4 -MNPs, were ...

7

Toxicity evaluation of Gd2O3@SiO2 nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo

Toxicity evaluation of Gd<sub>2</sub>O<sub>3</sub>@SiO<sub>2</sub> nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo

... Abstract: Poor toxicity characterization is one obstacle to the clinical deployment of Gd 2 O 3 @ SiO 2 core-shell nanoparticles (Gd-NPs) for use as magnetic resonance (MR) imaging contrast agents. ...

11

Oxygen-Ozone (O2-O3) Therapy in Peripheral Arterial Disease (PAD): A Review Study

<p>Oxygen-Ozone (O<sub>2</sub>-O<sub>3</sub>) Therapy in Peripheral Arterial Disease (PAD): A Review Study</p>

... transport 4 translocation from the intracellular compartment to the cellular ...− 2 /NO − 3 ratio, a marker of nitric ...that O 2 -O 3 therapy ...

16

The changes of T lymphocytes and cytokines in ICR mice fed with Fe3O4 magnetic nanoparticles

The changes of T lymphocytes and cytokines in ICR mice fed with Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles

... important role in regulating the body’s immune response. Th1 cells secrete interleukins such as IL-2 and INF- γ , whose main function is to promote cell-mediated immune response; they are involved in ...

6

Biocompatibility of Fe3O4@Au composite magnetic nanoparticles in vitro and in vivo

Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>@Au composite magnetic nanoparticles in vitro and in vivo

... 3 O 4 @Au composite ...3 O 4 @Au composite MNPs after intraperitoneal administration in mice was ...1, 2, 3, and 4 weeks after liver injection and no behavioral ...

15

Show all 10000 documents...

Related subjects